Mary Barbera, PhD, RN, BCBA-D presents her book “The Verbal Behavior Approach” at a Paris Workshop

« Mand, tact, intraverbal ! » Participants of Dr. Barbera’s Verbal Behavior workshop at the Le Chemin ABA VB Learning Center in Paris, France last week called out the different verbal operants. They were watching a video of a young, non-verbal, boy with autism learning to speak using the Verbal Behavior Approach. This group of […]

Online Program Offers Affordable Therapy for Autism

It is a known fact that children with autism suffer from sensory dysfunction. Sensory issues can range from mild to severe, and can manifest in many different ways. Occupational therapists trained in sensory integration can help, but their services are expensive, and may not always be covered by insurance. Mendability is an online program developed […]

Yoga Provides Relaxation Benefits to Children with Autism

Yoga as a complimentary treatment for autism is growing in popularity. A new book by South Florida yoga teacher Louise Goldberg provides techniques for teaching yoga poses to children with special needs. Titled “Yoga Therapy for Children with Autism and Special Needs”, published by W.W. Norton and company, this book offers ways to present poses […]

Utah Provides Free ABA Therapy for Autism through Medicaid’s Pilot Program

The Utah Department of Health issued a notice on their website that parents of an autistic child between the ages of two and six could enroll the child in a pilot program by Medicaid. Referred to as the Utah Medicaid Autism Waiver, this pilot program would treat about three hundred children through Applied Behavior Analysis […]

TRICARE will Require Authorization to Continue ABA Services to Military Families with Autistic Children

Starting July 25th, this Thursday, the military’s healthcare insurer, TRICARE, will enact stricter qualifications to their current policy regarding the continuation of Applied Behavioral Analysis services to families with autistic children. This cold affect more than 23,000 military dependents who have a diagnosis of an autism spectrum disorder. At the same time that TRICARE will expand […]

Herbal Remedies Display Potential in the Treatment of Autism

Recent research shows promise for the use of herbal remedies to treat autism. A recent study conducted in Japan examined the effects of yokukansan on the behavior of children with pervasive developmental disorder (PDD), which is one of the autism spectrum disorders. In this study, 20 children and teenagers aged 6 to 17 with diagnoses […]

Music an Alternative Communication Strategy for Autism

As reported yesterday, human voices does not trigger pleasure for many individuals on the autism spectrum. While loud sounds can cause a severe negative reaction, music can be a helpful education intervention if specifically design for the child. Music therapy has proved effective in helping the people with serious diseases like cancer and depression as it […]

Hugs for Autism

BioHug Technologies, an innovative technologies firm located in Haifa, Israel, has developed a product to help assist in the treatment of autism. The company has created the BioHug Vest, which is said to be a stress relief solution for those with autism. The company states on its website: “The BioHug Vest is an effective, portable, […]

Do the Benefits of Clozapine Outweigh the Risks?

Clozapine is approved by the United States Food and Drug Administration (FDA) solely for the use of treatment-resistant schizophrenia. Clozapine was the first atypical antipsychotic drug to be developed. Also known by brand names such as Clozaril, Denzapine, FazaClo, Leponex, and Zaponex, this drug is generally only used as a last resort in patients that […]

Clinical Trials Haulted for Promising Drug in the Treatment of Autism

 Seaside Therapeutics’ clinical trials for the drug Arbaclofen placarbil have recently been shutdown due to funding issues. On May 15, 2013, the sponsor of Arbaclofen sent an announcement to the clinics involved in the administration of the drug stating “We regret to inform you that Study 209FX303 [An Open-Label Extension Study to Evaluate the Safety, […]